To examine whether IL-6 activates STAT3 in SAIDS-NHL as it does in other target cells [26], LCL8664 cells were treated with IL-6, TGF-β1 or a combination of the two cytokines for time periods ranging from 0 to 60 minutes. The gene discussed is TGFB1; the disease is non-Hodgkin lymphoma.